Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL9861598 | 0.71 | NPSR1 (0.36) | CYP2C19BLMKDM4ECYP2D6NPSR1 | |
| Sulfuric Acid SCHEMBL9290734 | 0.71 | NPSR1 (0.36) | CYP2C19BLMKDM4ECYP2D6NPSR1 | |
| Sulfuric Acid SCHEMBL3475189 | 0.69 | KDM4E (0.48) | CYP2C19BLMKDM4ECYP2D6NPSR1 | |
| SCHEMBL11406977 | 0.66 | — | — | |
| SCHEMBL8390330 | 0.65 | — | — | |
| Sulfuric Acid SCHEMBL10751111 | 0.65 | KDM4E (0.50) | CYP2C19BLMKDM4ECYP2D6NPSR1 | |
| SCHEMBL4742316 | 0.64 | — | — | |
| Guanidine SCHEMBL8638683 | 0.64 | BLM (0.48) | CYP2C19BLMKDM4ECYP2D6NPSR1 | |
| Hydrochloric Acid SCHEMBL11409292 | 0.64 | GRIN2D (0.30) | — | |
| SCHEMBL9473153 | 0.63 | BLM (0.33) | CYP2C19BLMKDM4ELMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1501558-A1 | RESORBABLE PHARMACEUTICAL FORMULATION FOR THE CONTINUOUS RELEASE OF THROMBIN | Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) (DE) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003094983-A1 | RESORBABLE PHARMACEUTICAL FORMULATION FOR THE CONTINUOUS RELEASE OF THROMBIN | Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) (DE) | 2003-11-20 | — | — | WO | disclosed |